Skip to content
Lower risk Drug recall · FDA · Published December 6, 2016

Cipher Pharmaceuticals INOVA 4% Benzoyl Peroxide Pad Recall: Subpotent Drug Risk

Cipher Pharmaceuticals recalls INOVA 4% benzoyl peroxide pads due to inconsistent drug concentration. Products may not deliver claimed strength, risking ineffective acne treatment. Consumers should check product details and contact manufacturer for guidance.

🇺🇸 FDA recall #D-0237-2017DrugCipher Pharmaceuticals ›
Take action

Contact the company

Recalling firmCipher Pharmaceuticals US LLC115 Central Island St Ste 300 · Daniel Island, SC 29492-7320
✎ GovInfoNow plain-language explainer

What happened, in plain English

Cipher Pharmaceuticals is recalling INOVA 4% benzoy: peroxide pads because the drug concentration varies within the lot, meaning the product may not deliver the claimed strength. This could lead to ineffective acne treatment. Read more at govinfonow.com/recall/42140-cipher-pharmaceuticals-inova-4-benzoyl-peroxide-pad-recall-subpotent-drug.

Source Summary by GovInfoNow · govinfonow.com/recall/42140-cipher-pharmaceuticals-inova-4-benzoyl-peroxide-pad-recall-subpotent-drug · Updated October 8, 2026 · FDA enforcement record: FDA #D-0237-2017

Cite this page

“Cipher Pharmaceuticals INOVA 4% Benzoyl Peroxide Pad Recall: Subpotent Drug Risk.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42140-cipher-pharmaceuticals-inova-4-benzoyl-peroxide-pad-recall-subpotent-drug. Based on FDA recall #D-0237-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0237-2017%22&limit=1).

Why it’s dangerous

The product label claims 4% benzoyl peroxide, but testing shows variation in concentration outside product specifications. This means the pads may not deliver the intended strength for acne treatment, potentially leading to ineffective results.

Who’s affected

People who own or use the INOVA 4% benzoyl peroxide pads for acne treatment. Those most at risk are individuals relying on the product for consistent acne treatment.

How to tell if you have this one

Check for the product name 'INOVA 4% Benzoyl Peroxide Easy Pad' with 30 pads and 28 capsules. The lot number is 01316L02 and NDC code 68712-013-01.

  • Brand
    Cipher Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the product name 'INOVA 4% Benzoyl Peroxide Easy Pad' with 30 pads and 28 capsules, lot number 01316L02, and NDC code 68712-013-01.

Where it went and when

Where it was distributed

Distributed in 3 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: yesCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: yesAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “AZ, CO and OH.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Arizona, Colorado, Ohio.

Recall timeline

FDA published this recall 29 days after the firm started it.

1. Firm started the recall: Dec 6, 201612. FDA classified it Class III: Dec 28, 201623. Published in FDA’s Enforcement Report: Jan 4, 2017320162017
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0237-2017 (December 6, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0237-2017 to see it in context.
  • Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA